305 related articles for article (PubMed ID: 31250840)
1. Baloxavir marboxil: a novel cap-dependent endonuclease (CEN) inhibitor for the treatment of acute uncomplicated influenza.
Locke SC; Splawn LM; Cho JC
Drugs Today (Barc); 2019 Jun; 55(6):359-366. PubMed ID: 31250840
[TBL] [Abstract][Full Text] [Related]
2. Baloxavir Marboxil: The First Cap-Dependent Endonuclease Inhibitor for the Treatment of Influenza.
Yang T
Ann Pharmacother; 2019 Jul; 53(7):754-759. PubMed ID: 30674196
[TBL] [Abstract][Full Text] [Related]
3. Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial.
Ison MG; Portsmouth S; Yoshida Y; Shishido T; Mitchener M; Tsuchiya K; Uehara T; Hayden FG
Lancet Infect Dis; 2020 Oct; 20(10):1204-1214. PubMed ID: 32526195
[TBL] [Abstract][Full Text] [Related]
4. Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents.
Hayden FG; Sugaya N; Hirotsu N; Lee N; de Jong MD; Hurt AC; Ishida T; Sekino H; Yamada K; Portsmouth S; Kawaguchi K; Shishido T; Arai M; Tsuchiya K; Uehara T; Watanabe A;
N Engl J Med; 2018 Sep; 379(10):913-923. PubMed ID: 30184455
[TBL] [Abstract][Full Text] [Related]
5. [Baloxavir marboxil: a potent cap-dependent endonuclease inhibitor of influenza viruses].
Reina J; Reina N
Rev Esp Quimioter; 2019 Feb; 32(1):1-5. PubMed ID: 30676002
[TBL] [Abstract][Full Text] [Related]
6. Population Pharmacokinetic and Exposure-Response Analyses of Baloxavir Marboxil in Adults and Adolescents Including Patients With Influenza.
Koshimichi H; Tsuda Y; Ishibashi T; Wajima T
J Pharm Sci; 2019 May; 108(5):1896-1904. PubMed ID: 30557562
[TBL] [Abstract][Full Text] [Related]
7. Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018.
Takashita E; Kawakami C; Morita H; Ogawa R; Fujisaki S; Shirakura M; Miura H; Nakamura K; Kishida N; Kuwahara T; Mitamura K; Abe T; Ichikawa M; Yamazaki M; Watanabe S; Odagiri T;
Euro Surveill; 2019 Jan; 24(3):. PubMed ID: 30670142
[TBL] [Abstract][Full Text] [Related]
8. Baloxavir marboxil in Japanese patients with seasonal influenza: Dose response and virus type/subtype outcomes from a randomized phase 2 study.
Watanabe A; Ishida T; Hirotsu N; Kawaguchi K; Ishibashi T; Shishido T; Sato C; Portsmouth S; Tsuchiya K; Uehara T
Antiviral Res; 2019 Mar; 163():75-81. PubMed ID: 30684563
[TBL] [Abstract][Full Text] [Related]
9. Baloxavir Marboxil for Prophylaxis against Influenza in Household Contacts.
Ikematsu H; Hayden FG; Kawaguchi K; Kinoshita M; de Jong MD; Lee N; Takashima S; Noshi T; Tsuchiya K; Uehara T
N Engl J Med; 2020 Jul; 383(4):309-320. PubMed ID: 32640124
[TBL] [Abstract][Full Text] [Related]
10. Treatment-Emergent Influenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated Influenza.
Uehara T; Hayden FG; Kawaguchi K; Omoto S; Hurt AC; De Jong MD; Hirotsu N; Sugaya N; Lee N; Baba K; Shishido T; Tsuchiya K; Portsmouth S; Kida H
J Infect Dis; 2020 Jan; 221(3):346-355. PubMed ID: 31309975
[TBL] [Abstract][Full Text] [Related]
11. Baloxavir heralds a new era in influenza virus biology.
Kikuchi T; Watanabe A
Respir Investig; 2019 Jan; 57(1):1-2. PubMed ID: 30396860
[TBL] [Abstract][Full Text] [Related]
12. A retrospective observational study of the treatment of a nosocomial infection caused by oseltamivir-resistant influenza virus A with baloxavir marboxil.
Fujita M; Matsumoto H; Inafuku Y; Toyama J; Fujita J
Respir Investig; 2020 Sep; 58(5):403-408. PubMed ID: 32605828
[TBL] [Abstract][Full Text] [Related]
13. Baloxavir: First Global Approval.
Heo YA
Drugs; 2018 Apr; 78(6):693-697. PubMed ID: 29623652
[TBL] [Abstract][Full Text] [Related]
14. A network meta-analysis of the efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors for the treatment of influenza in otherwise healthy patients.
Taieb V; Ikeoka H; Ma FF; Borkowska K; Aballéa S; Tone K; Hirotsu N
Curr Med Res Opin; 2019 Aug; 35(8):1355-1364. PubMed ID: 30810054
[No Abstract] [Full Text] [Related]
15. Baloxavir Marboxil (Xofluza) for Influenza.
Erlich DR
Am Fam Physician; 2019 Dec; 100(12):776-777. PubMed ID: 31845775
[No Abstract] [Full Text] [Related]
16. Combination treatment with the cap-dependent endonuclease inhibitor baloxavir marboxil and a neuraminidase inhibitor in a mouse model of influenza A virus infection.
Fukao K; Noshi T; Yamamoto A; Kitano M; Ando Y; Noda T; Baba K; Matsumoto K; Higuchi N; Ikeda M; Shishido T; Naito A
J Antimicrob Chemother; 2019 Mar; 74(3):654-662. PubMed ID: 30476172
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of baloxavir marboxil against influenza in children.
Kakuya F; Haga S; Okubo H; Fujiyasu H; Kinebuchi T
Pediatr Int; 2019 Jun; 61(6):616-618. PubMed ID: 31195429
[No Abstract] [Full Text] [Related]
18. Successful treatment with baloxavir marboxil of a patient with peramivir-resistant influenza A/H3N2 with a dual E119D/R292K substitution after allogeneic hematopoietic cell transplantation: a case report.
Harada N; Shibata W; Koh H; Takashita E; Fujisaki S; Okamura H; Nanno S; Yamada K; Nakamae H; Hino M; Kakeya H
BMC Infect Dis; 2020 Jul; 20(1):478. PubMed ID: 32631240
[TBL] [Abstract][Full Text] [Related]
19. In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit.
Noshi T; Kitano M; Taniguchi K; Yamamoto A; Omoto S; Baba K; Hashimoto T; Ishida K; Kushima Y; Hattori K; Kawai M; Yoshida R; Kobayashi M; Yoshinaga T; Sato A; Okamatsu M; Sakoda Y; Kida H; Shishido T; Naito A
Antiviral Res; 2018 Dec; 160():109-117. PubMed ID: 30316915
[TBL] [Abstract][Full Text] [Related]
20. The Comparison of the Efficacy of Baloxavir and Neuraminidase Inhibitors for Patients with Influenza A in Clinical Practice.
Yoshii N; Tochino Y; Fujioka M; Sakazaki H; Maruyama N; Asai K; Kakeya H; Shintaku H; Kawaguchi T
Intern Med; 2020; 59(12):1509-1513. PubMed ID: 32536677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
